InvestorsHub Logo
Followers 1
Posts 348
Boards Moderated 0
Alias Born 03/05/2019

Re: None

Tuesday, 11/28/2023 4:15:16 PM

Tuesday, November 28, 2023 4:15:16 PM

Post# of 34625
The FDA on Tuesday said it has launched an investigation into reports about serious risk of T-cell malignancies with CAR-T therapies, including CAR-positive lymphoma, and is considering whether it needs to step in. The agency suggested that this risk applies to all currently approved BCMA- and CD19-directed autologous CAR-T immunotherapies, noting that T-cell malignancies have occurred in patients treated with "several products."
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News